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Oral iron acutely elevates bacterial 
growth in human serum
James H. Cross1, Richard S. Bradbury1,2, Anthony J. Fulford1,3, Amadou T. Jallow1, 
Rita Wegmüller1, Andrew M. Prentice1,3 & Carla Cerami4
Iron deficiency is the most common nutrient deficiency worldwide and routine supplementation is 
standard policy for pregnant mothers and children in most low-income countries. However, iron 
lies at the center of host-pathogen competition for nutritional resources and recent trials of iron 
administration in African and Asian children have resulted in significant excesses of serious adverse 
events including hospitalizations and deaths. Increased rates of malaria, respiratory infections, 
severe diarrhea and febrile illnesses of unknown origin have all been reported, but the mechanisms 
are unclear. We here investigated the ex vivo growth characteristics of exemplar sentinel bacteria  
in adult sera collected before and 4 h after oral supplementation with 2 mg/kg iron as ferrous  
sulfate. Escherichia coli, Yersinia enterocolitica and Salmonella enterica serovar Typhimurium (all  
gram-negative bacteria) and Staphylococcus epidermidis (gram-positive) showed markedly elevated 
growth in serum collected after iron supplementation. Growth rates were very strongly correlated 
with transferrin saturation (p < 0.0001 in all cases). Growth of Staphylococcus aureus, which 
preferentially scavenges heme iron, was unaffected. These data suggest that even modest oral 
supplements with highly soluble (non-physiological) iron, as typically used in low-income settings, 
could promote bacteremia by accelerating early phase bacterial growth prior to the induction of 
immune defenses.
Iron deficiency (ID) remains the most pervasive nutritional deficiency worldwide. The prevalence of 
ID in mothers and young children frequently exceeds 50% in low-income countries. Insufficient iron 
impairs growth and cognitive development in childhood1,2.
Low cost iron supplements are effective for the treatment of ID and in countries with ID rates of > 40%, 
the World Health Organization recommends universal iron supplementation of pregnant women and 
young children3–5. To overcome perceived limitations in the ability to absorb iron, supplements usually 
employ highly soluble forms of iron (ferrous sulfate or fumarate) given in rather large non-physiological 
bolus doses. The wisdom of these policies has long been questioned6,7 and has come under serious 
scrutiny starting in 2006 with the premature termination of a large trial in Pemba, Tanzania after sig-
nificant increases in serious adverse outcomes (hospitalizations and deaths) in young children receiving 
iron-folate supplements were seen8. The emphasis was originally focused on malaria as the causative 
agent for the increases in morbidity and mortality during iron supplementation9 but subsequent trials 
have described excesses of other infections in groups randomized to iron or multiple micronutrients 
containing iron10–15. These findings have paralyzed iron supplementation policies.
The underlying mechanisms and the types of organisms responsible for these clinical and epide-
miological observations remain unclear. Recent field studies suggest that oral iron supplementation in 
children increases susceptibility to bacterial infections, particularly diarrhea13,16, alters the gut microbi-
ota16,17, and increases the virulence of many common bacterial enteropathogens18–20.
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Numerous animal studies over many decades have shown that administration of iron in diverse forms 
accelerates the growth of peritoneally-injected pathogens, causing a septicemia with rapidly fatal out-
comes21,22. We here examine the possibility in humans that a simple oral dose of supplemental iron could 
promote bacterial growth in serum. We used a series of ex vivo bacterial growth assays with sentinel 
organisms that were selected on the basis of their varying modes of pathogenesis and abilities to scavenge 
iron from the host.
Results
Oral iron supplementation increases iron parameters in serum. To determine the effects of oral 
iron supplementation on bacterial growth in human serum, we enrolled 48 normal healthy non-ane-
mic male subjects [mean ± SD: Hemoglobin (Hgb) = 14.5 ± 1.13 g/dL; Mean Corpuscular Volume 
(MCV) = 83.8 ± 5.5 fL; Ferritin = 62.8 ± 53.2 ng/mL]. Volunteers donated serum immediately before, and 
then four hours after, oral ingestion of 400 mg ferrous sulfate (containing the equivalent of 130 mg of 
elemental iron). Transferrin saturation (TSAT) increased from 42.1% (± 12.5%, SD) to 75.7% (± 18.1%, 
SD) and total serum iron increased from 30.3 μmol/L (± 10.2μmol/L, SD) to 53.0μmol/L (± 15.8μmol/L, 
SD) four hours after iron supplementation.
Effects of oral iron supplementation on ex vivo bacterial growth in serum. We next measured 
the growth of the five species of sentinel bacteria in the baseline and post-dose sera. To account for the 
between-subject variance in the starting transferrin saturation levels, we used mixed statistical models to 
allow two nested higher levels of variation: patient and bleed (pre- and post-iron supplementation). This 
enabled us to independently analyze the effects of TSAT and iron supplementation.
S. aureus, an organism with a strong preference for heme-derived iron23, behaved differently from the 
other four bacteria (Fig. 1A). Iron supplementation had no impact on the general pattern of the growth 
curve (p = 0.3). Both the time to reach peak doubling time (p = 0.21), and the doubling time during the 
exponential growth phase (p = 0.78) were also unchanged by iron supplementation (Table  1). Growth 
did not correlate with TSAT (p = 0.08) (Table 2).
S. epidermidis (Fig. 1B) demonstrated an initial delay in growth in comparison with the other species. 
Iron supplementation influenced the overall pattern of the growth curve (p < 0.0001). Specifically, iron 
supplementation reduced the lag phase, the time to reach peak doubling time (p = 0.001), and increased 
the doubling time during the exponential growth phase (p < 0.001) (Table  1). The very strong effect 
of iron on the overall increase in bacterial growth (X2 = 55 (approximately), p < 0.0001) was equally 
explained using pre/post supplementation as a dichotomized variable or by TSAT (Table 2).
S. Typhimurium (Fig.  2A) and E. coli (Fig.  2B) both showed highly significant differences in their 
growth curves after iron supplementation (p < 0.0001). The doubling times post-iron supplementation 
were significantly shorter than pre-iron supplementation (p < 0.0001), but time to reach peak doubling 
time was unaffected by treatment (Table  1). Transferrin saturation had a very strong effect on overall 
Figure 1. Growth of sentinel gram-positive bacteria in human serum before and after oral iron 
supplementation. S. aureus (A) and S. epidermidis (B) were grown in serum from subjects before (blue) 
and after (red) oral iron supplementation with 400 mg ferrous sulfate (containing the equivalent of 130 mg 
of elemental iron). The thicker central lines represent the fitted curves for an average individual and the 
thinner lines the 95% confidence intervals for these estimates. The points show individual values of OD620. 
Curves were derived from mixed effects models fitting degree-four orthogonal polynomials in time to 
log(OD620), where OD620 is the mean optical density of the three replicates at time (t).
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growth rates of both S. Typhimurium (X2 = 348, p < 0.0001) and E. coli (X2 = 300, p < 0.0001), com-
parable to, indeed a little larger than, that of iron supplementation in both S. Typhimurium (X2 = 213, 
p < 0.0001) and E. coli (X2 = 221, p < 0.0001). For E. coli, iron supplementation (X2 = 35, p < 0.0001) and 
TSAT (X2 = 69, p < 0.0001) each had significant effects on bacterial growth after controlling for the other. 
The same held true for S. Typhimurium growth where both iron supplementation (X2 = 22, p = 0.0004) 
and TSAT (X2 = 105, p < 0.0001) each had significant effects on bacterial growth after controlling for 
the other (Table 2). This is likely to be because, in addition to capturing the effect of supplementation, 
transferrin saturation also explains differences between individuals.
Analysis of Growth S. aureus S. epidermidis E. coli S. Typhimurium Y. enterocolitica
Growth Curve
X2 (5 df) 6.05 65.70 225.00 232.00 117.70
p-value 0.30 < 0.0001 < 0.0001 < 0.0001 < 0.0001
Time to Reach Peak 
Doubling Time (hours)
Mean pre (CI95%) 3.34 (3.21, 3.47) 13.7 (11.8, 15.7) 1.86 (0.50, 3.21) Not Applicable - No MAX
Not Applicable - 
No MAX
Mean post (CI95%) 3.25 (3.12, 3.38) 10.70 (10.0, 11.4) 2.56 (2.32, 2.79)
z − 1.26 − 3.24 1.03
p-value 0.21 0.001 0.3
Doubling Time During 
Exponential Phase 
(hours)
Mean pre (CI95%) 1.74 (1.67, 1.81) 4.82 (4.2, 5.5) 2.14 (1.99, 2.29) 2.03 (1.81, 2.26) 4.96 (3.0, 7.0)
Mean post (CI95%) 1.75 (1.68, 1.82) 3.36 (3.0, 3.7) 1.50 (1.44, 1.56) 1.60 (1.37, 1.62) 4.37 (2.8, 6.0)
z 0.28 − 4.56 − 8.04 − 4.34 − 1.73
p-value 0.78 < 0.001 < 0.0001 < 0.001 0.62
Table 1.  Statistical analysis of ex vivo bacterial growth assays. For each species of bacterium we 
compared its growth pre- and post-iron supplementation by examining differences in (1) Growth Curve, i.e. 
general pattern curve of the overall growth trajectories; (2) Time to Reach Peak Doubling Time, i.e. the time 
at which the rate of increase in log(OD620) was at a maximum; and (3) Doubling Time During Exponential 
Growth Phase.
Hypothesis Testing S. aureus S. epidermidis E. coli S. Typhimurium Y. enterocolitica
(1) Iron supp. 
affects growth
X2 (5 df) 5.92 55.70 221.00 213.00 108.17
p-value 0.31 <0.0001 <0.0001 <0.0001 <0.0001
(2) Iron supp. 
affects growth 
independently of 
TSAT
X2 (5 df) 8.85 7.53 35.10 22.40 32.71
p-value 0.12 0.18 <0.0001 0.0004 <0.0001
(3) TSAT affects 
growth
X2 (5 df) 9.79 55.50 300.00 348.00 120.41
p-value 0.08 <0.0001 <0.0001 <0.0001 <0.0001
(4) TSAT 
affects growth 
independently 
of iron 
supplementation
X2 (5 df) 12.70 6.22 69.50 105.00 36.89
p-value 0.03 0.29 <0.0001 <0.0001 <0.0001
Table 2.  Statistical testing of the independent effects of iron supplementation and transferrin 
saturation (TSAT). Three models (mathematical equations) were fitted for each bacterial species: 
(a) iron supplementation × (t1 t2 t3 t4), i.e. iron supplementation, the time polynomials and their 
interactions; (b) TSAT × (t1 t2 t3 t4), i.e. TSAT, the time polynomials and their interactions; (c) (iron 
supplementation + TSAT) × (t1 t2 t3 t4), i.e. iron supplementation, TSAT and both their interactions 
with the time polynomials. We employed the likelihood ratio test to compare models for which the 
growth patterns were and were not dependent on TSAT or iron supplementation. The effects of iron 
supplementation and TSAT were derived from models (a) and (b) respectively and refer to the joint 
effects of the variable and the terms for its interaction with the time polynomials. The independent 
(conditional) effects of iron supplementation after controlling for TSAT, and TSAT after controlling for 
iron supplementation, are both derived from model (c) and again refer to the joint effects of the variable 
and the terms for its interaction with the time polynomials. For each bacterial species, each of the 
following four hypotheses were tested: (1) iron supplementation has an impact on bacterial growth; (2) iron 
supplementation has an impact on bacterial growth independently of TSAT; (3) TSAT has an impact on 
bacterial growth; and (4) TSAT has an impact on bacterial growth independently of iron supplementation. 
Significance was determined using a chi-squared test. Chi-squared and p-values are reported.
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For Y. enterocolitica (Fig.  2C), the maximum growth rate was difficult to locate. In fact, although 
the growth curves clearly differ significantly (p < 0.0001), the doubling times at one hour did not differ 
significantly. As was the case for S. Typhimurium and E. coli, TSAT had an impact on growth (X2 = 120, 
p < 0.0001) as did iron supplementation (X2 = 108, p < 0.0001). Additionally, iron supplementation 
(X2 = 33, p < 0.0001) and TSAT (X2 = 37, p < 0.0001) each had significant effects on bacterial growth 
after controlling for the other (Table 2).
Discussion
The biologically useful redox characteristics of the Fe(II) to Fe(III) transition place iron apart from other 
nutrients. Additionally, it lies at the epicenter of the host-pathogen battle for resource control. Host 
defense mechanisms to withhold iron from invading pathogens are some of the most evolutionarily 
conserved innate strategies against infection24, but most bacterial species have evolved counter-acting 
strategies for pirating host iron including: (1) receptors that bind transferrin, lactoferrin or hemoglobin; 
and (2) low molecular weight siderophores that acquire iron from host proteins or from low molecular 
weight iron compounds25.
The potential health threat posed by exogenous iron, repeatedly demonstrated in animal models25, 
has tended to be overlooked in clinical settings. The recent iron trials with adverse outcomes in children 
in developing countries8,10–15 have prompted new mechanistic studies providing experimental verifica-
tion that oral iron adversely modifies the gut microbiome17,26 and increases the virulence of pathogenic 
enteric bacteria18,20. In this study we focused on the issue of systemic, as opposed to enteric, bacterial 
infections building upon prior knowledge that iron can precipitate septicemias (for instance, based on 
the disastrous outcomes of intramuscular iron-dextran administration to Polynesian neonates27).
The ex vivo assays we describe here show that customary oral supplementation with highly-soluble 
iron as ferrous sulfate can profoundly affect the growth dynamics of four of the five sentinel species we 
studied. This could potentially undermine a key component of innate immunity allowing such organisms 
to achieve overwhelming numbers by the time adaptive immune defense mechanisms are up-regulated. 
Note that the very strong correlations between TSAT and growth rates emphasizes the importance of this 
variable even in the presence of likely inter-individual differences in other iron-related (e.g. lipocalin-2, 
haptoglobin) and other (e.g. defensins) non-cellular defense mechanisms within the sera.
Recent molecular insights into human iron metabolism have challenged the basic pillars on which 
public health strategies involving highly soluble iron supplements have been developed. The prior belief 
that humans are constitutionally inefficient at absorbing iron, and hence require large non-physiological 
doses taken apart from food, is now overturned by the knowledge that hepcidin actively down-regulates 
iron acquisition especially in the presence of an infectious threat24. The dual regulation of hepcidin 
by iron and infection (inflammation) underscores the threat posed by exogenous iron. An increase of 
hepcidin caused by an infection might have the evolutionary function of decreasing further iron uptake 
from the intestine to reduce circulating iron fuel for microorganisms. This suggests that we should not 
interfere via high dose iron supplements.
Figure 2. Growth of sentinel gram-negative bacteria in human serum before and after oral iron 
supplementation. S. Typhimurium (A), E. coli (B) and Y. entercolitica (C) were grown in serum from 
subjects before (blue) and after (red) oral iron supplementation with 400 mg ferrous sulfate (containing the 
equivalent of 130 mg of elemental iron). The thicker central lines represent the fitted curves for an average 
individual and the thinner lines the 95% confidence intervals for these estimates. The points show individual 
values of OD620. Curves were derived from mixed effects models fitting degree-four orthogonal polynomials 
in time to log(OD620), where OD620 is the mean optical density of the three replicates at  
time (t).
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Transferrin saturation is homeostatically controlled with a normal range between 15–50% in males. 
Our data show that increasing TSAT from a mean of 42% to 76% profoundly stimulated bacterial growth 
with a continuous association across all levels of TSAT. The role of TSAT in mediating host susceptibility 
to infection has been known for almost half a century28. However, neither the strength of this association, 
nor the ability of acute increases in TSAT following iron doses to so rapidly favor bacterial growth, have 
been previously appreciated. The dose level selected for the adults in this study was based on that most 
frequently used for young children with iron deficiency (2 mg/kg/day), however our subjects were iron 
replete. In iron deficient children, hepcidin would be down-regulated to allow maximal iron absorption29 
and hence TSAT would be expected to rise even further. Although a higher percentage of increase can 
be expected, the TSAT baseline will be lower and may still end up lower than in iron replete men. In the 
event of accidental ingress of pathogens through a cut, abrasion or leaky gut, these high levels of TSAT 
could precipitate a fulminant bacteremia before other cognate immune defenses have time to respond.
Iron absorbed from a natural food matrix, or even when ferrous sulfate is given with food30, is released 
much more slowly and causes minor deviations in TSAT and in non-transferrin bound iron (NTBI)30 
which, according to the data presented here, would be much less likely to promote bacterial growth. In 
regions of the world where iron-rich foods are scarce, or too costly, supplementation with slow release 
nano-molecular formulations that mimic a food matrix31 may provide a safer option and might addition-
ally reduce the adverse effects of unabsorbed iron on the gut microbiota. Field trials of such compounds 
are warranted. Additional safe approaches to supplement iron include the use of oral bovine lactoferrin32.
Materials and Methods
Subjects. Forty-eight male Gambian subjects (averaging 40y; range 21–64y) were recruited. Subjects 
had no history of fever, illness or anti-microbial use during the preceding seven days; were malaria rapid 
test negative and were non-anemic (Hemoglobin > 12 g/dL). All patients donated blood between 9 and 
10 am, on an empty stomach, immediately prior to and four hours after taking 400 mg ferrous sulfate 
orally. Food was provided two hours after iron supplementation.
Informed consent was obtained from all subjects. This study was approved by the Gambian 
Government/MRC Joint Ethics Committee (SCC1312v2) and by the University of North Carolina 
Institutional Review Board (protocol #143044). All experiments were performed in accordance with the 
approved guidelines.
Biochemical Parameters. Complete blood counts were obtained using a Medonic M series (Boule 
Diagnostics Int AB, Stockholm, Sweden) hematology analyzer. Serum biochemical parameters including 
serum iron, transferrin, ferritin and transferrin saturation were obtained using a Cobas Integra 400 plus 
(Roche, Basel, Switzerland) biochemistry analyzer.
Bacterial Growth assays. Staphylococcus aureus (strain NCTC8325), Staphylococcus epidermidis 
(FDA strain PCI1200, ATCC12228), Salmonella enterica serovar Typhimurium (strain LT2, ATCC19585) 
and Escherichia coli (strain Crooks, ATCC8739) were grown overnight for 18 hours at 37 °C in 5 mL 
iron free minimal growth media, Iscove’s Modified Dulbecco’s Medium (IMDM, Invitrogen). This was 
conducted in air with continuous shaking (250 rpm). A high-virulence, siderophore producing Yersinia 
enterocolitica (strain WA-314, ATCC51871) was grown in IMDM containing 10 mM ethylene glycol 
tetraacetic acid (EGTA, Sigma) (pH7). All growth assays were run in triplicate in IMDM containing 
50% heat-inactivated human serum. Bacterial growth was monitored by measuring the optical density 
at 620 nm (OD620) hourly for 12 hours (Staphylococcus aureus, Salmonella enterica serovar Typhimurium, 
and Escherichia coli) and then at 20, 28, 36 hours (Staphylococcus epidermidis and Yersinia enterocolitica) 
using a Multiscan FC ELISA plate reader (Thermo Scientific).
Statistical analysis. We analyzed the growth assays with a mixed model using a quartic polynomial 
in Stata12 (StataCorp, College Station, TX). We used the logarithm of the mean of the three replicate 
OD readings at each time point as the response variable and modeled growth trajectories by fitting this 
to orthogonal polynomials (to degree 4) in time using mixed effects models with random intercept and 
coefficients due to patient and, nested within patient, bleed (pre and post). In effect, therefore, the growth 
trajectory for the ith blood sample was modeled by an equation of the form:
( ) = (β + τ ) + (β + τ ) + (β + τ ) + (β + τ ) + (β + τ ) + ε ,log[OD t ] t t t ti 0 0i 1 1i 2 2i
2
3 3i
3
4 4i
4
it
where t is time since inoculation, the β s are estimated coefficients and the τ s and ε are the random 
effects.
For each species of bacterium, we compared its growth pre- and post-iron supplementation by exam-
ining differences in (1) Growth Curve i.e. general pattern of the overall growth trajectories; (2) Time to 
Reach Peak Doubling Time, i.e. the time at which the rate of increase in log[OD] was at a maximum and 
(iii) Doubling Time During Exponential Growth Phase, i.e. when the doubling time was at its greatest, 
or, if the lag phase was not detectable at 1 hour after inoculation. We estimated the timing of the maxi-
mum slope by setting the second derivative with respect to time of the deterministic component of the 
model to zero. We calculated the doubling time at time t as log(2)/(slope of log[OD(t)]). We employed 
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the likelihood ratio test to compare models for which the growth patterns were and were not dependent 
on the transferrin saturation or iron supplementation. We used the delta method to obtain the 95% con-
fidence intervals for the time at which maximum slope occurred and the doubling time.
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